Search clinical trials for: Gelastic Seizure

Total 1204 results

UCB Pharma

Completed

Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures (PASS)

Epilepsies, Partial

France, Germany, United Kingdom, Spain, Netherlands
Bial - Portela C S.A.

Completed

Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures

Partial Epilepsy

Netherlands, Poland, Italy, Russian Federation, Ukraine
GlaxoSmithKline

Completed

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures (IR)

Epilepsy

Bulgaria, Belgium, Thailand, Denmark, Russian Federation, Italy, Spain, Ukraine, Netherlands, Germany, France, Poland
Cyberonics, Inc.

Completed

PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1 (PuLsE 2)

Epilepsy

France, Belgium, Italy, United Kingdom, Germany, Canada, Netherlands
UCB Pharma

Completed

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Epilepsies, Partial

United States
UCB Pharma

Completed

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Partial Seizures With or Without Secondary Generalization

Germany
UCB Pharma

Completed

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Epilepsy
UCB Pharma

Completed

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Epilepsy

Poland, United States, Mexico, Russian Federation
UCB Pharma

Completed

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Epilepsy

United States, Poland, Mexico, Russian Federation
UCB Pharma GmbH

Completed

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug (VITOBA)

Epilepsies, Partial

Germany
Emory University
Baxter Healthcare Corporation

Terminated

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Seizure Disorder | Epilepsy, Partial | Epilepsy, Cryptogenic | Autoimmune Diseases, Nervous System | Limbic Encephalitis

United States
Vidya Raman

Completed

Revisiting Survey Investigating Why Patients Are Not Receiving Home Anti-convulsant Medication Prior to Surgery/or Procedure Involving General Anesthesia

Seizures

United States
Eisai Inc.

Completed

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

Partial Seizures

China
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Partial Onset Seizures

Japan
Eisai Inc.

Completed

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

Partial Seizures

Italy
Eisai Co., Ltd.
Eisai Limited

Completed

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Epilepsy

Latvia
Eisai Inc.

Completed

To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Refractory Partial Seizures

United States, France, Germany, Italy, United Kingdom, Belgium, Israel, South Africa, Finland, Russian Federation, Austria, Netherlands, Sweden, India
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

Refractory Partial Epilepsy

Portugal
Jazz Pharmaceuticals

Completed

Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Epilepsy

United States, Finland
Eisai GmbH

Terminated

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Epilepsy

Germany
Cyberonics, Inc.

Terminated

Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures

Epilepsy

Sweden, United Kingdom, Austria, Belgium, Germany
Assistance Publique - Hôpitaux de Paris

Completed

Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (SAMU-KEPPRA)

Status; Epilepticus, Tonic-clonic

France
Wolfson Medical Center

Completed

Seizures Post Intracerebral Hemorrhage

Post Cerebral Hemorrhage
Sarah Lisanby
University of Texas; Stanley Medical Research Institute

Completed

Magnetic Seizure Therapy (MST) for the Treatment of Major Depression (MST-2)

Major Depressive Disorder

United States
Fundació Institut de Recerca de l'Hospital de la...

Completed

Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome

Hand-foot Syndrome

Spain
Upsher-Smith Laboratories

Completed

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Epilepsy

United States, Australia, Poland, Belgium, Spain, Argentina, Israel, India, South Africa, Greece, Russian Federation, Chile, Germany, New Zealand, Hungary, Canada
Hôpital Armand Trousseau
Hopital Universitaire Robert-Debre; Centre Hospitalier Intercommunal Creteil; Versailles Hospital and other collaborators

Completed

Nervous System Infections Among Patients With Febrile Seizure

Encephalitis | Meningitis | Seizure | Febrile Seizure

France
University of Alabama at Birmingham
UCB Pharma

Terminated

A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide

Traumatic Brain Injury

United States
Vikel Ltd
Abertawe Bro Morgannwg University NHS Trust

Unknown

Tonicity Monitor For Epilepsy and Hypertonic Disorders

Epilepsy

United Kingdom
University of Cincinnati
Mayfield Clinic & Spine Institute

Completed

Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention (Keppra)

Traumatic Brain Injury | Subarachnoid Hemorrhage

United States
Bistro Study Group
Barts & The London NHS Trust; Groupe Hospitalier Pitie-Salpetriere

Completed

Biomarkers In Seizure To Predict Recurrence and Severe Outcomes (BISTRO)

Seizures | Copeptin | S-100b Protein

France, United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Epilepsy | Seizures | Partial Seizure Disorder

United States, Australia, France, Belgium, Taiwan, Spain, Argentina, Poland, India, Ukraine, Finland, Korea, Republic of, Russian Federation, Chile, Thailand, Hungary, Israel, New Zealand, Canada, Mexico, Norway, Netherlands, South...
Children's Hospitals and Clinics of Minnesota

Completed

Animal Assisted Therapy in a Pediatric Setting (AAT)

Stroke | Behavior Problems | Feeding Disorder | Developmental Delays | Cancers | Global Developmental Delay | Seizures Disorders | Developmental Delay in Feeding

United States
Emory University
The University of Texas Health Science Center, Houston; National Institute... and other collaborators

Completed

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Depression | Epilepsy | Depressive Symptoms | Seizure Disorder

United States
Chinese University of Hong Kong

Completed

Mindfulness-based Psychotherapy for Drug-resistant Epilepsy

Epilepsy | Stress

Hong Kong
Supernus Pharmaceuticals, Inc.
Parexel

Completed

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures (PROSPER1)

Epilepsies, Partial

United States, Poland, Mexico, Bulgaria, Romania, Canada, Russian Federation, Croatia
National Center for Complementary and Integrative...

Completed

Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures (FOS)

Epilepsy

United States
SK Life Science, Inc.
The Epilepsy Study Consortium

Completed

Efficacy of YKP3089 in Patients With Photosensitive Epilepsy

Epilepsy

United States
NeuroPace

Completed

RNS® System Feasibility Study

Epilepsy

United States
Eisai Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.

Partial, Generalized and Combined Seizures

India
Brigham and Women's Hospital
Shared Health, Chattanooga, TN

Unknown

Evaluation of a Regional Electronic Health Information Exchange's Clinical Health Record

Impact of Health Information Exchange on Patient Care | (Focus on Diabetes, Asthma, Hypertension, CHF, COPD, CAD, | Gastroenteritis, Seizures, and Bacterial Pneumonia)
Emory University
UCB Pharma

Completed

IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

Tonic-clonic Seizure

United States
UCB Pharma

Completed

Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures

Epilepsy
UCB Pharma

Completed

Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

Epilepsy, Partial
UCB Pharma

Completed

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

Epilepsy, Partial
UCB Pharma

Completed

Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures

Generalized Convulsive Epilepsy
Emory University
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy

Epilepsy | Cognition Disorders | Seizure

United States, United Kingdom
Johnson & Johnson Taiwan Ltd

Completed

First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients (TEAMS)

Epilepsy
UCB Pharma

Completed

Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

Generalized Convulsive Epilepsy
UCB Pharma

Completed

A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures

Absence Seizures

Search clinical trials for: Gelastic Seizure

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations